Vahanian & Associates Financial Planning Inc. Jasper Therapeutics, Inc. Call Options Transaction History

Vahanian & Associates Financial Planning Inc.

  • $24.5 Million
  • Q4 2023

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding JSPR

# of Institutions
1
Shares Held
5.63M
Call Options Held
0
Put Options Held
0
View Full List

About Jasper Therapeutics, Inc.

JSPR Quotes by TradingView
  • Ticker JSPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,073,300
  • Market Cap $698M
  • Description
  • Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...
More about JSPR
Track This Portfolio

Track Vahanian & Associates Financial Planning Inc. Portfolio

Follow Vahanian & Associates Financial Planning Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vahanian & Associates Financial Planning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vahanian & Associates Financial Planning Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email